US FDA drafts 5-yr plan to strengthen e-submission of drug applications, data
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is inviting feedback on a range of IT-related initiatives that it plans to undertake over the next five years to support the review of prescription and generic drug applications1,2. Among other things, the agency plans to implement by June 2014 certain changes to the electronic common technical document or eCTD that is used by drug companies for making regulatory submissions.
You may also be interested in...
Canada Aims To Implement eCTD v4 By 2022
Canada joins other international regulators in announcing plans to implement the next major revision of the electronic common technical document format (eCTD v4). A roadmap has been issued to help pharmaceutical companies prepare and plan for this change.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.